CBER revises internal procedures for processing clinical holds, NDAs and BLAs
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyComplianceRegulatory Intelligence/PolicyRegulatory writing/documentationUnited StatesRegulatory NewsJoanne S. EglovitchBiologics/ biosimilars/ vaccinesBiotechnologyComplianceRegulatory Intelligence/PolicyRegulatory writing/documentationUnited States